Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24weeks of aromatase inhibition

Masakazu Toi, Shigehira Saji, Norikazu Masuda, Katsumasa Kuroi, Nobuaki Sato, Hiroyuki Takei, Yutaka Yamamoto, Shinji Ohno, Hiroko Yamashita, Kazufumi Hisamatsu, Kenjiro Aogi, Hiroji Iwata, Masahiro Takada, Takayuki Ueno, Shigetoyo Saji, Niramol Chanplakorn, Takashi Suzuki, Hironobu Sasano

Research output: Contribution to journalArticlepeer-review

42 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24weeks of aromatase inhibition'. Together they form a unique fingerprint.

Medicine & Life Sciences